Koidl Christoph, Bozic Michael, Burmeister Anja, Hess Markus, Marth Egon, Kessler Harald H
Institute of Hygiene, Medical University of Graz, Universitaetsplatz 4, 8010 Graz, Austria.
J Clin Microbiol. 2007 Feb;45(2):347-50. doi: 10.1128/JCM.01303-06. Epub 2006 Dec 6.
Molecular detection of Bordetella pertussis DNA is a sensitive and specific method for the rapid diagnosis of pertussis. In this study, a new molecular assay for the detection and differentiation of Bordetella spp. based on automated DNA extraction and real-time PCR was evaluated. The analytical sensitivity of the new assay was determined by Probit analysis of serial dilutions of both cloned PCR products IS481 and IS1001 and cell suspensions of B. pertussis, B. parapertussis, and B. bronchiseptica. The specificity was analyzed by testing a number of pathogens producing respiratory infections. Moreover, a total of 92 clinical samples were investigated. The results were compared to those obtained by an in-house assay based on manual DNA extraction, followed by real-time PCR and detection of IS481. The analytical sensitivity of the new assay for the detection of IS481 and IS1001 was determined to be 2.2 and 1.2 genome equivalents/mul, respectively. The analytical sensitivity for the detection of B. pertussis, B. parapertussis, and B. bronchiseptica was determined to be 1.6, 1.0, and 2.7 genome equivalents/mul, respectively. When clinical specimens were tested with the new assay, 46 of 92 were found to be positive for Bordetella DNA. With the in-house assay, 45 samples tested positive. The new molecular assay proved to be suitable for the rapid diagnosis of pertussis in the routine diagnostic laboratory.
百日咳博德特氏菌DNA的分子检测是一种用于百日咳快速诊断的灵敏且特异的方法。在本研究中,对一种基于自动化DNA提取和实时PCR的用于检测和区分博德特氏菌属的新分子检测方法进行了评估。通过对克隆的PCR产物IS481和IS1001以及百日咳博德特氏菌、副百日咳博德特氏菌和支气管败血博德特氏菌细胞悬液的系列稀释进行概率分析,确定了新检测方法的分析灵敏度。通过检测多种引起呼吸道感染的病原体来分析特异性。此外,共调查了92份临床样本。将结果与基于手工DNA提取、随后进行实时PCR和检测IS481的内部检测方法所获得的结果进行比较。新检测方法对IS481和IS1001检测的分析灵敏度分别确定为2.2和1.2个基因组当量/微升。对百日咳博德特氏菌、副百日咳博德特氏菌和支气管败血博德特氏菌检测的分析灵敏度分别确定为1.6、1.0和2.7个基因组当量/微升。当用新检测方法检测临床标本时,92份中有46份被发现百日咳博德特氏菌DNA呈阳性。用内部检测方法时,45份样本检测呈阳性。新分子检测方法被证明适用于常规诊断实验室中百日咳的快速诊断。